Back to Articles
Lumonus Inks Joint Venture with NY Cancer Centre to Scale AI Oncology

The Australian Financial Review

READ

Details

Date Published
8 Apr 2026
Priority Score
1
Australian
Yes
Created
8 Apr 2026, 06:00 am

Description

The agreement comes five months after Lumonus closed its $25 million Series B financing round.

Summary

Australian-founded digital oncology platform Lumonus has partnered with a major New York cancer treatment center to expand its specialized AI diagnostic and treatment applications. The joint venture focuses on scaling digital health infrastructure for oncology, representing a narrow application of AI in clinical healthcare settings. While relevant to the commercialization of Australian AI technology, the article does not address frontier AI safety risks, catastrophic potential, or broader existential risk policy. This development highlights the integration of AI within established medical governance frameworks rather than novel safety initiatives for autonomous systems.

Body

CompaniesStreet TalkPrint articleSarah Thompson, Kanika Sood and Emma RapaportApr 8, 2026 – 12.06pmLumonus, the digital oncology platform spun out of cancer services provider GenesisCare, and chaired by former Anchorage Capital Group boss Merrick Howes, has inked a joint venture agreement with a leading cancer treatment centre in New York.Dealmaker Merrick Howes is the chairman of Lumonus. Renee NowytargerLoading...Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at sarah.thompson@afr.comKanika Sood is a journalist based in Sydney who writes for the Street Talk column. Email Kanika at kanika.sood@afr.com.auEmma Rapaport is a co-editor of the Street Talk column. Prior to that, she was a markets reporter at The Australian Financial Review. Connect with Emma on Twitter. Email Emma at emma.rapaport@afr.comSaveLog in or Subscribe to save articleShareCopy linkCopiedEmailLinkedInTwitterFacebookCopy linkCopiedShare via...Gift this articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? LoginLicense articleFollow the topics, people and companies that matter to you.Find out moreRead MoreStreet TalkCapital raisingVenture capitalPrivate equityCancerSee all Street Talk